Prof. Dr. Martin Schlee
Institute of Clinical Chemistry & Clinical Pharmacology
martin.schlee@uni-bonn.de View member: Prof. Dr. Martin Schlee
Science advances
Innate immune and stress responses must be tightly regulated to prevent aberrant activation in the absence of pathogens. The RNA helicase DHX36 has been implicated in viral RNA sensing, but its role in immune regulation is not fully understood. Here, we show that DHX36 functions as a rheostat that restrains immune activation under homeostatic conditions while modulating antiviral signaling. Exposure to double-stranded RNA reduces DHX36 activity, enabling immune activation. In contrast, cells lacking DHX36 adopt a constitutively activated immune state characterized by accumulation of RNA G-quadruplex structures, protein kinase R (PKR)-dependent stress granule formation, and elevated interferon-stimulated gene expression. These cells also display enhanced responsiveness to the viral RNA sensor retinoic acid-inducible gene I (RIG-I) and more effectively suppress replication of a yellow fever virus replicon. Together, our findings position DHX36 as a key regulator of the type I interferon response, linking RNA structure surveillance to coordinated PKR- and RIG-I-dependent antiviral signaling and maintenance of immune homeostasis.
PMID: 42213826
Institute of Clinical Chemistry & Clinical Pharmacology
martin.schlee@uni-bonn.de View member: Prof. Dr. Martin SchleeInstitute for Experimental Hematology and Transfusion Medicine
ebartok@uni-bonn.de View member: Prof. Dr. Eva BartokInstitute of Clinical Chemistry & Clinical Pharmacology
katrin.paeschke@ukbonn.de View member: Prof. Dr. Katrin Paeschke